Funds holding Lakefront Biotherapeutics NV
ISIN US36315X1019 · Belgium · LEI 549300QKJ78IY0IOV655
- Fund holders
- 15
- Of which ETFs
- 6 9 other funds
- Value held
- 46.1M $
This issuer has other securities: Lakefront Biotherapeutics NV (BE0003818359)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Columbia Overseas Value Fund COLUMBIA FUNDS SERIES TRUST | 746,801 | 21.2M $ | 0.31 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 292,580 | 8.8M $ | 0.10 % | as of Jun 30, 2026 ↗ |
| Columbia Variable Portfolio - Overseas Core Fund Columbia Funds Variable Series Trust II | 280,317 | 8.4M $ | 0.22 % | as of Jun 30, 2026 ↗ |
| Columbia Overseas Core Fund Columbia Funds Series Trust II | 90,697 | 2.6M $ | 0.26 % | as of May 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 67,945 | 1.9M $ | 1.19 % | as of May 31, 2026 ↗ |
| Avantis International Equity ETF American Century ETF Trust | 30,449 | 863.2K $ | 0.01 % | as of May 31, 2026 ↗ |
| International Value Fund VALIC Co I | 28,283 | 801.8K $ | 0.16 % | as of May 31, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 18,273 | 518K $ | 0.05 % | as of May 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 16,569 | 450.8K $ | 0.13 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 10,150 | 287.8K $ | 0.00 % | as of May 31, 2026 ↗ |
| Avantis International Small Cap Equity ETF American Century ETF Trust | 6,762 | 191.7K $ | 0.06 % | as of May 31, 2026 ↗ |
| Avantis International Equity Fund American Century ETF Trust | 2,478 | 70.3K $ | 0.01 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 794 | 22.5K $ | 0.03 % | as of May 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 548 | 15.5K $ | 0.02 % | as of May 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 100 | 3K $ | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.19 % | as of May 31, 2026 ↗ |
| Columbia Overseas Value Fund COLUMBIA FUNDS SERIES TRUST | 0.31 % | as of May 31, 2026 ↗ |
| Columbia Overseas Core Fund Columbia Funds Series Trust II | 0.26 % | as of May 31, 2026 ↗ |
| Columbia Variable Portfolio - Overseas Core Fund Columbia Funds Variable Series Trust II | 0.22 % | as of Jun 30, 2026 ↗ |
| International Value Fund VALIC Co I | 0.16 % | as of May 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 0.13 % | as of Jul 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.10 % | as of Jun 30, 2026 ↗ |
| Avantis International Small Cap Equity ETF American Century ETF Trust | 0.06 % | as of May 31, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 0.05 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.03 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 15 | -3 | 1,592,746 | -9.9 % |
| 2026Q2 | 18 | -3 | 1,767,816 | -3.3 % |
| 2026Q1 | 21 | -4 | 1,827,551 | +10.1 % |
| 2025Q4 | 25 | 0 | 1,660,103 | -8.4 % |
| 2025Q3 | 25 | -1 | 1,812,792 | -21.0 % |
| 2025Q2 | 26 | +1 | 2,294,846 | -14.4 % |
| 2025Q1 | 25 | -1 | 2,680,424 | -14.5 % |
| 2024Q4 | 26 | -8 | 3,135,151 | -28.0 % |
| 2024Q3 | 34 | +1 | 4,353,540 | -15.5 % |
| 2024Q2 | 33 | -1 | 5,153,404 | +0.6 % |
| 2024Q1 | 34 | 0 | 5,123,982 | +1.4 % |
| 2023Q4 | 34 | 5,053,508 |
Institutional managers
89 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 16,707,477 | 501.2M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 3,785,991 | 113.6M $ | as of Mar 31, 2026 |
| Madison Avenue Partners, LP | 2,465,179 | 74M $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 1,667,119 | 50M $ | as of Mar 31, 2026 |
| Prosight Management, LP | 1,550,000 | 46.5M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 1,424,674 | 42.7M $ | as of Mar 31, 2026 |
| DME Capital Management, LP | 482,746 | 14.5M $ | as of Mar 31, 2026 |
| SEGALL BRYANT & HAMILL, LLC | 426,412 | 12.8M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 332,125 | 10M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 315,400 | 9.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 312,106 | 9.4M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 215,718 | 6.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 175,289 | 5.3M $ | as of Mar 31, 2026 |
| DAFNA Capital Management LLC | 130,175 | 3.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 124,428 | 3.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 107,912 | 3.2M $ | as of Mar 31, 2026 |
| OLD MISSION CAPITAL LLC | 95,591 | 2.9M $ | as of Mar 31, 2026 |
| Man Group plc | 80,209 | 2.4M $ | as of Mar 31, 2026 |
| Hudson Bay Capital Management LP | 77,500 | 2.3M $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 66,536 | 2M $ | as of Mar 31, 2026 |
| ALPS ADVISORS INC | 53,661 | 1.6M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 45,942 | 1.4K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 45,371 | 1.4M $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 45,168 | 1.4K $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 38,790 | 1.2M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Lakefront Biotherapeutics NV". https://titelia.com/en/stocks/lakefront-biotherapeutics-nv-US36315X1019